Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“MedWatch Plus” Will Create Single Adverse Event Reporting Venue

This article was originally published in The Tan Sheet

Executive Summary

FDA's vision for a revamped MedWatch system includes a single portal for adverse event submissions from a variety of sources
Advertisement

Related Content

Congress Says GAO Report Supports Increasing Supplement Oversight
Congress Says GAO Report Supports Increasing Supplement Oversight
Congress Says GAO Report Supports Increasing Supplement Oversight
Current MedWatch Form Stays While More Changes Could Occur Later In 2008
Current MedWatch Form Stays While More Changes Could Occur Later In 2008
FDA, NIH Developing Online AER Portal Accessible To Other Federal Agencies
Supplement AER Draft Guidance Omits Answers, But Recognizes Complexities
Bipartisan AER Bill Requires Reporting For All OTC Drugs, Supplements
Bipartisan AER Bill Requires Reporting For All OTC Drugs, Supplements
“Drug Watch” Sent Back To The Drawing Board; FDA Turning To MedWatch?

Topics

Advertisement
UsernamePublicRestriction

Register

PS099542

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel